{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:37:30Z","timestamp":1782146250979,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.035","type":"journal-article","created":{"date-parts":[[2007,10,5]],"date-time":"2007-10-05T18:21:22Z","timestamp":1191608482000},"page":"8110-8113","source":"Crossref","is-referenced-by-count":33,"title":["Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S."],"prefix":"10.1016","volume":"25","author":[{"given":"Shalini L.","family":"Kulasingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pagliusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2007.09.035_bib1","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.vaccine.2006.05.113","article-title":"Chapter 7: achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.035_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2007.09.035_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2007.09.035_bib4","first-page":"1","article-title":"Sexual behavior and selected health measures: men and women 15\u201344 years of age, United States, 2002","author":"Mosher","year":"2005","journal-title":"Adv Data"},{"key":"10.1016\/j.vaccine.2007.09.035_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.035_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2007.09.035_bib7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2007.09.035_bib8","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","article-title":"Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral","volume":"288","author":"Kulasingam","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.09.035_bib9","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2007.09.035_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3322\/canjclin.57.2.105","article-title":"Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines","volume":"57","author":"Solomon","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2007.09.035_bib11","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1158\/1055-9965.EPI-05-0914","article-title":"Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000\u20132002","volume":"15","author":"Coughlin","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2007.09.035_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2007.09.035_bib13","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.035_bib14","first-page":"28","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"EID"},{"key":"10.1016\/j.vaccine.2007.09.035_bib15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2007.09.035_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6602049","article-title":"Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort","volume":"91","author":"Peto","year":"2004","journal-title":"Br J Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2007.09.035_bib17","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.vaccine.2006.05.061","article-title":"Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T15:26:10Z","timestamp":1556897170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":17,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010699"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}